ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,624 | -26.1% | 56,636 | +41.5% | 0.02% | -25.0% |
| Q2 2023 | $856,599 | +32.7% | 40,028 | +150.7% | 0.03% | +18.5% |
| Q1 2023 | $645,745 | +68.9% | 15,968 | +94.3% | 0.03% | +35.0% |
| Q4 2022 | $382,394 | -24.1% | 8,220 | -15.4% | 0.02% | 0.0% |
| Q3 2022 | $504,000 | -46.2% | 9,712 | -50.9% | 0.02% | -50.0% |
| Q2 2022 | $936,000 | +153.0% | 19,800 | +135.7% | 0.04% | +11.1% |
| Q2 2021 | $370,000 | +31.2% | 8,400 | +25.5% | 0.04% | -25.0% |
| Q4 2020 | $282,000 | – | 6,694 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |